1. Home
  2. BUI vs WVE Comparison

BUI vs WVE Comparison

Compare BUI & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Utility Infrastructure & Power Opportunities Trust

BUI

BlackRock Utility Infrastructure & Power Opportunities Trust

N/A

Current Price

$24.43

Market Cap

692.8M

Sector

Finance

ML Signal

N/A

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$3.88

Market Cap

744.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BUI
WVE
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
692.8M
744.8M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
BUI
WVE
Price
$24.43
$3.88
Analyst Decision
Strong Buy
Analyst Count
0
18
Target Price
N/A
★ $18.53
AVG Volume (30 Days)
72.7K
★ 2.8M
Earning Date
01-01-0001
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $3,704,000.00
Revenue This Year
N/A
$20.53
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 149.43
52 Week Low
$24.58
$3.56
52 Week High
$30.80
$21.73

Technical Indicators

Market Signals
Indicator
BUI
WVE
Relative Strength Index (RSI) 31.31 36.57
Support Level N/A N/A
Resistance Level $27.85 $6.33
Average True Range (ATR) 0.33 0.21
MACD -0.05 -0.02
Stochastic Oscillator 14.44 38.99

Price Performance

Historical Comparison
BUI
WVE

About BUI BlackRock Utility Infrastructure & Power Opportunities Trust

BlackRock Utility Infrastructure & Power Opportunities Trust is a closed-end management investment company. Its investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities issued by companies that are engaged in the Utilities, Infrastructure, and Power Opportunities business segments anywhere in the world and by employing writing (selling) call and put options.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: